Verastem (VSTM) Receivables (2018 - 2026)

Verastem (VSTM) recorded quarterly Receivables of $10.2 million in Q1 2026, up 15.26% quarter-over-quarter from $8.8 million in Q4 2025.

Verastem (VSTM) Receivables (2018 - 2026) Analysis & Trends

Verastem's Receivables history runs 9 years deep, the most recent figure standing at $10.2 million for Q1 2026.

  • In Q1 2026, Receivables changed N/A year-over-year to $10.2 million; the TTM figure through Mar 2026 stood at $10.2 million (changed N/A YoY), while the FY2025 annual figure was $8.8 million, changed N/A from the prior year.
  • Receivables was $10.2 million for Q1 2026 at Verastem, up from $8.8 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $10.2 million in Q1 2026 to a low of $64000.0 in Q2 2023.
  • Historically, Receivables has averaged $4.1 million across 5 years, with a median of $2.5 million in 2022.
  • The sharpest annual moves came in 2022 and 2024: Receivables slumped 81.49% in 2022, then soared 15525.0% in 2024.
  • A 5-year view of Receivables shows it stood at $127000.0 in 2022, then slumped by 49.61% to $64000.0 in 2023, then jumped by 15525.0% to $10.0 million in 2024, then slipped by 11.87% to $8.8 million in 2025, then grew by 15.26% to $10.2 million in 2026.
  • The last three Receivables figures came in at $10.2 million (Q1 2026), $8.8 million (Q4 2025), and $6.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 13.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 2.00 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Verastem 407.42 Mn 225.74 Mn 15.90 Mn 10.16 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 10.16 Mn
Dec 31, 2025 8.81 Mn
Sep 30, 2025 6.72 Mn
Jun 30, 2025 2.08 Mn
Jun 30, 2024 10.00 Mn
Jun 30, 2023 64,000.00
Dec 31, 2022 127,000.00
Sep 30, 2022 199,000.00
Jun 30, 2022 331,000.00
Mar 31, 2022 2.85 Mn
Dec 31, 2021 686,000.00
Sep 30, 2021 235,000.00
Jun 30, 2021 606,000.00
Mar 31, 2021 1.23 Mn
Dec 31, 2020 239,000.00
Sep 30, 2020 5.69 Mn
Jun 30, 2020 1.50 Mn
Mar 31, 2020 3.33 Mn
Dec 31, 2019 2.52 Mn
Sep 30, 2019 2.20 Mn